Lyell Immunopharma, Inc. (LYEL) P/S ratio

P/S ratio today
8069.6×

Only 1 fiscal year of P/S ratio is on record here for Lyell Immunopharma, Inc. (LYEL); a history needs at least 3. Lyell Immunopharma, Inc. (LYEL) trades at 8069.6× its revenue per share for fiscal 2025. Figures as of 18 Nov 2026, 13:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
8069.6×
P/S ratio, fiscal 2022
10.1×
Fiscal years on record
12022–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; one is on record here for Lyell Immunopharma, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Lyell Immunopharma, Inc. P/S ratio, year by year

Lyell Immunopharma, Inc. (LYEL) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today8069.6×—$13.67—
2025——$30.78$0.00
2024——$12.80$0.00
2023——$38.80$0.01
202210.1×—$69.40$6.85
2021——$154.80—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on LYEL

Lyell Immunopharma, Inc., figure by figure

Lyell Immunopharma, Inc. (LYEL) overview: price, valuation and scorecard

Lyell Immunopharma, Inc. P/S ratio: questions and answers

What is Lyell Immunopharma, Inc.'s P/S ratio?

Lyell Immunopharma, Inc. (LYEL) trades at 8069.6× its revenue per share for fiscal 2025.

How is Lyell Immunopharma, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Lyell Immunopharma, Inc. (LYEL) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/LYEL/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.